Undervalued Small-Cap Healthcare Stocks on TSX December 2024

December 25, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

TSX Venture Exchange

The TSX Venture Exchange is a stock exchange headquartered in Calgary, Alberta, Canada. It is an exchange for the securities of early-stage businesses.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
ENTG Entourage Health 0.01 0.03 162.66 182319 3 0.00 0.0
PINK Perimeter Medical Imaging 0.38 0.85 122.86 51927 25 0.00 0.0
PCLO PharmaCielo 0.09 0.20 121.16 189786 15 0.00 0.0
MRVL Marvel Biosciences 0.17 0.36 115.96 39229 7 0.00 0.0
HEM Hemostemix 0.07 0.13 90.02 59081 6 0.00 0.0
IBO Universal Ibogaine 0.01 0.02 88.53 31384 3 0.00 0.0
NPTH NeuPath Health 0.19 0.36 87.77 161996 11 0.00 0.0
WAVE Waverley Pharma 0.01 0.02 73.81 13922 1 0.00 0.0
DB Decibel Cannabis Co 0.07 0.13 69.39 303654 31 0.00 0.0
CRBK Carebook Technologies 0.06 0.10 64.99 16498 6 0.00 0.0
All data provided as at market close December 23, 2024.

Company Details

Entourage Health

ENTG:TSX-V

Close Price

0.01

Our Valuation

0.03

% Difference

162.66

Market Cap ($M)

3

P/E Ratio

0.0

Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution.

Access the stockcalc valuation


Perimeter Medical Imaging

PINK:TSX-V

Close Price

0.38

Our Valuation

0.85

% Difference

122.86

Market Cap ($M)

25

P/E Ratio

0.0

Perimeter Medical Imaging AI Inc is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, imaging tools to address high unmet medical needs.

Access the stockcalc valuation


PharmaCielo

PCLO:TSX-V

Close Price

0.09

Our Valuation

0.20

% Difference

121.16

Market Cap ($M)

15

P/E Ratio

0.0

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

Access the stockcalc valuation


Marvel Biosciences

MRVL:TSX-V

Close Price

0.17

Our Valuation

0.36

% Difference

115.96

Market Cap ($M)

7

P/E Ratio

0.0

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Hemostemix

HEM:TSX-V

Close Price

0.07

Our Valuation

0.13

% Difference

90.02

Market Cap ($M)

6

P/E Ratio

0.0

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

Access the stockcalc valuation


Universal Ibogaine

IBO:TSX-V

Close Price

0.01

Our Valuation

0.02

% Difference

88.53

Market Cap ($M)

3

P/E Ratio

0.0

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Access the stockcalc valuation


NeuPath Health

NPTH:TSX-V

Close Price

0.19

Our Valuation

0.36

% Difference

87.77

Market Cap ($M)

11

P/E Ratio

0.0

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions.

Access the stockcalc valuation


Waverley Pharma

WAVE:TSX-V

Close Price

0.01

Our Valuation

0.02

% Difference

73.81

Market Cap ($M)

1

P/E Ratio

0.0

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Bortezomib, Pemetrexed, Capecitabine, and Temozolomide, among others.

Access the stockcalc valuation


Decibel Cannabis Co

DB:TSX-V

Close Price

0.07

Our Valuation

0.13

% Difference

69.39

Market Cap ($M)

31

P/E Ratio

0.0

Decibel Cannabis Co Inc is engaged in the cannabis operations business. It is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers as well as the direct sale of products through its retail locations to end customers.

Access the stockcalc valuation


Carebook Technologies

CRBK:TSX-V

Close Price

0.06

Our Valuation

0.10

% Difference

64.99

Market Cap ($M)

6

P/E Ratio

0.0

Carebook Technologies Inc is engaged in the development and commercialization of a complete end-to-end digital health platform that features assessment, reporting, and targeted solutions offered through an array of selected partners and resellers, and its primary customers are large employers across a variety of industries and pharmacies. Its products include Corehealth, Pharmacy and Wellness Checkpoint.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Entourage Health and Perimeter Medical Imaging are the most undervalued Small-Cap Healthcare stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-december-2024
Entourage Health $ENTG and Perimeter Medical Imaging $PINK are the most undervalued Healthcare stocks on the #TSX. See the full list: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-december-2024
Entourage Health and Perimeter Medical Imaging are the most undervalued Small-Cap Healthcare stocks on the TSX. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-small-cap-healthcare-stocks-tsx-december-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.